William A. Mehan

William A. Mehan

Auto-generated profile, based on publicly available information

William A. Mehan

From the Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
WMWilliam A. Mehan
William A. Mehan
JBJames A. Brink
James A. Brink
JHJoshua A. Hirsch
Joshua A. Hirsch

25 June 2020 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
Min LangMin Lang
Min Lang
KBK. Buch
K. Buch
MLM D Li
M D Li
WMW.A. Mehan
W.A. Mehan
ALA.L. Lang
A.L. Lang
SRS.P. Rincon
S.P. Rincon
SUMMARY: There is increasing evidence to suggest that complications of coronavirus disease 2019 (COVID-19) infection are not only limited to the pulmonary system but can also involve the central nervous system. Here, we report 6 critically ill patients with COVID-19 infection and neuroimaging findings of leukoencephalopathy. While these findings are nonspecific, we postulate that they may be a delayed response to the profound hypoxemia the patients experienced due to the infection. No abnormal enhancement, hemorrhage, or perfusion abnormalities were noted on MR imaging. In addition, Severe Acute Respiratory Syndrome coronavirus 2 was not detected in the CSF collected from the 2 patients who underwent lumbar puncture. Recognition of COVID-19-related leukoencephalopathy is important for appropriate clinical management, disposition, and prognosis.

6 August 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
WMW.A. Mehan
W.A. Mehan
BYB.C. Yoon
B.C. Yoon
Min LangMin Lang
Min Lang
LILi
Li
SRS. Rincon
S. Rincon
KBK. Buch
K. Buch
SUMMARY: Myalgia is a previously reported symptom in patients with COVID-19 infection; however, the presence of paraspinal myositis has not been previously reported. We report MR imaging findings of the spine obtained in a cohort of 9 patients with COVID-19 infection who presented to our hospital between March 3, 2020 and May 6, 2020. We found that 7 of 9 COVID-19 patients (78%) who underwent MR imaging of the spine had MR imaging evidence of paraspinal myositis, characterized by intramuscular edema and/or enhancement. Five of these 7 patients had a prolonged hospital course (greater than 25 days). Our knowledge of the imaging manifestations of COVID-19 infection is expanding. It is important for clinicians>a to be aware of the relatively high frequency of paraspinal myositis in this small cohort of patients with COVID-19 infection.

17 December 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
MLM D Li
M D Li
Min LangMin Lang
Min Lang
FDF. Deng
F. Deng
KCK. Chang
K. Chang
KBK. Buch
K. Buch
JKJ. Kalpathy-Cramer
J. Kalpathy-Cramer
BACKGROUND AND PURPOSE: The coronavirus disease 2019 (COVID-19) pandemic has led to decreases in neuroimaging volume. Our aim was to quantify the change in acute or subacute ischemic strokes detected on CT or MR imaging during the pandemic using natural language processing of radiology reports. MATERIALS AND METHODS: We retrospectively analyzed 32,555 radiology reports from brain CTs and MRIs from a comprehensive stroke center, performed from March 1 to April 30 each year from 2017 to 2020, involving 20,414 unique patients. To detect acute or subacute ischemic stroke in free-text reports, we trained a random forest natural language processing classifier using 1987 randomly sampled radiology reports with manual annotation. Natural language processing classifier generalizability was evaluated using 1974 imaging reports from an external dataset. RESULTS: The natural language processing classifier achieved a 5-fold cross-validation classification accuracy of 0.97 and an F1 score of 0.74, with a slight underestimation (−5%) of actual numbers of acute or subacute ischemic strokes in cross-validation. Importantly, cross-validation performance stratified by year was similar. Applying the classifier to the complete study cohort, we found an estimated 24% decrease in patients with acute or subacute ischemic strokes reported on CT or MR imaging from March to April 2020 compared with the average from those months in 2017–2019. Among patients with stroke-related order indications, the estimated proportion who underwent neuroimaging with acute or subacute ischemic stroke detection significantly increased from 16% during 2017–2019 to 21% in 2020 (P = .01). The natural language processing classifier performed worse on external data. CONCLUSIONS: Acute or subacute ischemic stroke cases detected by neuroimaging decreased during the COVID-19 pandemic, though a higher proportion of studies ordered for stroke were positive for acute or subacute ischemic strokes. Natural language processing approaches can help automatically track acute or subacute ischemic stroke numbers for epidemiologic studies, though local classifier training is important due to radiologist reporting style differences.

31 January 2022 in Current Problems in Diagnostic Radiology
Verified
Journal Article
Closed access
WMWilliam A. Mehan
William A. Mehan
MGMichael S. Gee
Michael S. Gee
NENatalie Egan
Natalie Egan
PJPhilip E. Jones
Philip E. Jones
JBJames A. Brink
James A. Brink
JHJoshua A. Hirsch
Joshua A. Hirsch

10 September 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
BYB.C. Yoon
B.C. Yoon
KBK. Buch
K. Buch
Min LangMin Lang
Min Lang
BAB.P. Applewhite
B.P. Applewhite
LILi
Li
SRS.P. Rincon
S.P. Rincon
BACKGROUND AND PURPOSE: Coronavirus disease 2019 (COVID-19) is increasingly being recognized for its multiorgan involvement, including various neurological manifestations. We examined the frequency of acute intracranial abnormalities seen on CT and/or MR imaging in patients with COVID-19 and investigated possible associations between these findings and clinical parameters, including length of hospital stay, requirement for intubation, and development of acute kidney injury. MATERIALS AND METHODS: This was a retrospective study performed at a large academic hospital in the United States. A total of 641 patients presented to our institution between March 3, 2020, and May 6, 2020, for treatment of coronavirus disease 2019, of whom, 150 underwent CT and/or MR imaging of the brain. CT and/or MR imaging examinations were evaluated for the presence of hemorrhage, infarction, and leukoencephalopathy. The frequency of these findings was correlated with clinical variables, including body mass index, length of hospital stay, requirement for intubation, and development of acute kidney injury as documented in the electronic medical record. RESULTS: Of the 150 patients, 26 (17%) had abnormal CT and/or MR imaging findings, with hemorrhage in 11 of the patients (42%), infarction in 13 of the patients (50%), and leukoencephalopathy in 7 of the patients (27%). Significant associations were seen between abnormal CT/MR imaging findings and intensive care unit admission (P = .039), intubation (P = .004), and acute kidney injury (P = .030). CONCLUSIONS: A spectrum of acute neuroimaging abnormalities was seen in our cohort of patients with coronavirus disease 2019, including hemorrhage, infarction, and leukoencephalopathy. Significant associations between abnormal neuroimaging studies and markers of disease severity (intensive care unit admission, intubation, and acute kidney injury) suggest that patients with severe forms of coronavirus disease 2019 may have higher rates of neuroimaging abnormalities.